Free Trial

Booz Allen Hamilton (BAH) Competitors

Booz Allen Hamilton logo
$73.34 +1.75 (+2.44%)
Closing price 03:59 PM Eastern
Extended Trading
$73.40 +0.06 (+0.08%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BAH vs. CCRN, SAIC, CACI, LDOS, and CTSH

Should you buy Booz Allen Hamilton stock or one of its competitors? MarketBeat compares Booz Allen Hamilton with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Booz Allen Hamilton include Cross Country Healthcare (CCRN), Science Applications International (SAIC), CACI International (CACI), Leidos (LDOS), and Cognizant Technology Solutions (CTSH).

How does Booz Allen Hamilton compare to Cross Country Healthcare?

Cross Country Healthcare (NASDAQ:CCRN) and Booz Allen Hamilton (NYSE:BAH) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

Booz Allen Hamilton has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Country Healthcare$1.05B0.40-$94.85M-$3.05N/A
Booz Allen Hamilton$11.41B0.78$935M$6.7310.90

Cross Country Healthcare presently has a consensus price target of $12.72, indicating a potential downside of 3.16%. Booz Allen Hamilton has a consensus price target of $93.33, indicating a potential upside of 27.26%. Given Booz Allen Hamilton's higher possible upside, analysts clearly believe Booz Allen Hamilton is more favorable than Cross Country Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Country Healthcare
1 Sell rating(s)
9 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.90
Booz Allen Hamilton
4 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.80

In the previous week, Cross Country Healthcare had 14 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 20 mentions for Cross Country Healthcare and 6 mentions for Booz Allen Hamilton. Booz Allen Hamilton's average media sentiment score of 0.79 beat Cross Country Healthcare's score of -0.03 indicating that Booz Allen Hamilton is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cross Country Healthcare
2 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
2 Very Negative mention(s)
Neutral
Booz Allen Hamilton
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cross Country Healthcare has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.32, suggesting that its stock price is 68% less volatile than the broader market.

Booz Allen Hamilton has a net margin of 7.35% compared to Cross Country Healthcare's net margin of -9.84%. Booz Allen Hamilton's return on equity of 76.79% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Country Healthcare-9.84% -0.74% -0.54%
Booz Allen Hamilton 7.35%76.79%10.95%

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 6.3% of Cross Country Healthcare shares are held by company insiders. Comparatively, 0.9% of Booz Allen Hamilton shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Booz Allen Hamilton beats Cross Country Healthcare on 11 of the 16 factors compared between the two stocks.

How does Booz Allen Hamilton compare to Science Applications International?

Science Applications International (NASDAQ:SAIC) and Booz Allen Hamilton (NYSE:BAH) are related mid-cap companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Booz Allen Hamilton has a net margin of 7.35% compared to Science Applications International's net margin of 4.93%. Booz Allen Hamilton's return on equity of 76.79% beat Science Applications International's return on equity.

Company Net Margins Return on Equity Return on Assets
Science Applications International4.93% 33.15% 9.44%
Booz Allen Hamilton 7.35%76.79%10.95%

Science Applications International pays an annual dividend of $1.48 per share and has a dividend yield of 1.6%. Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.2%. Science Applications International pays out 19.2% of its earnings in the form of a dividend. Booz Allen Hamilton pays out 35.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Booz Allen Hamilton has raised its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Booz Allen Hamilton had 4 more articles in the media than Science Applications International. MarketBeat recorded 6 mentions for Booz Allen Hamilton and 2 mentions for Science Applications International. Science Applications International's average media sentiment score of 1.71 beat Booz Allen Hamilton's score of 0.79 indicating that Science Applications International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Science Applications International
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Booz Allen Hamilton
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Science Applications International presently has a consensus target price of $110.78, indicating a potential upside of 19.57%. Booz Allen Hamilton has a consensus target price of $93.33, indicating a potential upside of 27.26%. Given Booz Allen Hamilton's higher probable upside, analysts clearly believe Booz Allen Hamilton is more favorable than Science Applications International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Science Applications International
1 Sell rating(s)
7 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.18
Booz Allen Hamilton
4 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.80

Science Applications International has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.32, suggesting that its share price is 68% less volatile than the broader market.

Booz Allen Hamilton has higher revenue and earnings than Science Applications International. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Science Applications International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Science Applications International$7.26B0.55$358M$7.6912.05
Booz Allen Hamilton$11.41B0.78$935M$6.7310.90

76.0% of Science Applications International shares are held by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are held by institutional investors. 0.4% of Science Applications International shares are held by insiders. Comparatively, 0.9% of Booz Allen Hamilton shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Booz Allen Hamilton beats Science Applications International on 13 of the 19 factors compared between the two stocks.

How does Booz Allen Hamilton compare to CACI International?

Booz Allen Hamilton (NYSE:BAH) and CACI International (NYSE:CACI) are both it consulting & other services companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Booz Allen Hamilton has higher revenue and earnings than CACI International. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than CACI International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Booz Allen Hamilton$11.41B0.78$935M$6.7310.90
CACI International$8.63B1.29$499.83M$24.2420.86

Booz Allen Hamilton currently has a consensus target price of $93.33, suggesting a potential upside of 27.26%. CACI International has a consensus target price of $641.50, suggesting a potential upside of 26.87%. Given Booz Allen Hamilton's higher possible upside, analysts clearly believe Booz Allen Hamilton is more favorable than CACI International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Booz Allen Hamilton
4 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.80
CACI International
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.85

Booz Allen Hamilton has a net margin of 7.35% compared to CACI International's net margin of 5.86%. Booz Allen Hamilton's return on equity of 76.79% beat CACI International's return on equity.

Company Net Margins Return on Equity Return on Assets
Booz Allen Hamilton7.35% 76.79% 10.95%
CACI International 5.86%15.90%6.86%

Booz Allen Hamilton has a beta of 0.32, suggesting that its stock price is 68% less volatile than the broader market. Comparatively, CACI International has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market.

91.8% of Booz Allen Hamilton shares are held by institutional investors. Comparatively, 86.4% of CACI International shares are held by institutional investors. 0.9% of Booz Allen Hamilton shares are held by company insiders. Comparatively, 1.1% of CACI International shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, CACI International had 14 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 20 mentions for CACI International and 6 mentions for Booz Allen Hamilton. CACI International's average media sentiment score of 1.01 beat Booz Allen Hamilton's score of 0.79 indicating that CACI International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Booz Allen Hamilton
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
CACI International
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

CACI International beats Booz Allen Hamilton on 10 of the 17 factors compared between the two stocks.

How does Booz Allen Hamilton compare to Leidos?

Booz Allen Hamilton (NYSE:BAH) and Leidos (NYSE:LDOS) are both it consulting & other services companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Booz Allen Hamilton presently has a consensus target price of $93.33, suggesting a potential upside of 27.26%. Leidos has a consensus target price of $193.64, suggesting a potential upside of 54.23%. Given Leidos' stronger consensus rating and higher possible upside, analysts plainly believe Leidos is more favorable than Booz Allen Hamilton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Booz Allen Hamilton
4 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.80
Leidos
0 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.62

Leidos has a net margin of 8.15% compared to Booz Allen Hamilton's net margin of 7.35%. Booz Allen Hamilton's return on equity of 76.79% beat Leidos' return on equity.

Company Net Margins Return on Equity Return on Assets
Booz Allen Hamilton7.35% 76.79% 10.95%
Leidos 8.15%31.92%11.23%

In the previous week, Leidos had 20 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 26 mentions for Leidos and 6 mentions for Booz Allen Hamilton. Booz Allen Hamilton's average media sentiment score of 0.79 beat Leidos' score of 0.47 indicating that Booz Allen Hamilton is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Booz Allen Hamilton
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Leidos
9 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
5 Negative mention(s)
1 Very Negative mention(s)
Neutral

Leidos has higher revenue and earnings than Booz Allen Hamilton. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Leidos, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Booz Allen Hamilton$11.41B0.78$935M$6.7310.90
Leidos$17.17B0.92$1.45B$10.9211.50

Booz Allen Hamilton has a beta of 0.32, meaning that its share price is 68% less volatile than the broader market. Comparatively, Leidos has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market.

Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.2%. Leidos pays an annual dividend of $1.72 per share and has a dividend yield of 1.4%. Booz Allen Hamilton pays out 35.1% of its earnings in the form of a dividend. Leidos pays out 15.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Booz Allen Hamilton has increased its dividend for 14 consecutive years and Leidos has increased its dividend for 6 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

91.8% of Booz Allen Hamilton shares are owned by institutional investors. Comparatively, 76.1% of Leidos shares are owned by institutional investors. 0.9% of Booz Allen Hamilton shares are owned by company insiders. Comparatively, 0.8% of Leidos shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Leidos beats Booz Allen Hamilton on 14 of the 20 factors compared between the two stocks.

How does Booz Allen Hamilton compare to Cognizant Technology Solutions?

Booz Allen Hamilton (NYSE:BAH) and Cognizant Technology Solutions (NASDAQ:CTSH) are both it consulting & other services companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Cognizant Technology Solutions has a net margin of 10.41% compared to Booz Allen Hamilton's net margin of 7.35%. Booz Allen Hamilton's return on equity of 76.79% beat Cognizant Technology Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Booz Allen Hamilton7.35% 76.79% 10.95%
Cognizant Technology Solutions 10.41%17.50%12.94%

In the previous week, Cognizant Technology Solutions had 12 more articles in the media than Booz Allen Hamilton. MarketBeat recorded 18 mentions for Cognizant Technology Solutions and 6 mentions for Booz Allen Hamilton. Booz Allen Hamilton's average media sentiment score of 0.79 beat Cognizant Technology Solutions' score of 0.51 indicating that Booz Allen Hamilton is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Booz Allen Hamilton
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cognizant Technology Solutions
5 Very Positive mention(s)
4 Positive mention(s)
1 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

Cognizant Technology Solutions has higher revenue and earnings than Booz Allen Hamilton. Cognizant Technology Solutions is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Booz Allen Hamilton$11.41B0.78$935M$6.7310.90
Cognizant Technology Solutions$21.11B1.03$2.23B$4.6010.00

Booz Allen Hamilton currently has a consensus target price of $93.33, suggesting a potential upside of 27.26%. Cognizant Technology Solutions has a consensus target price of $73.33, suggesting a potential upside of 59.37%. Given Cognizant Technology Solutions' stronger consensus rating and higher probable upside, analysts plainly believe Cognizant Technology Solutions is more favorable than Booz Allen Hamilton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Booz Allen Hamilton
4 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.80
Cognizant Technology Solutions
0 Sell rating(s)
12 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.45

91.8% of Booz Allen Hamilton shares are held by institutional investors. Comparatively, 92.4% of Cognizant Technology Solutions shares are held by institutional investors. 0.9% of Booz Allen Hamilton shares are held by insiders. Comparatively, 0.4% of Cognizant Technology Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Booz Allen Hamilton has a beta of 0.32, indicating that its share price is 68% less volatile than the broader market. Comparatively, Cognizant Technology Solutions has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.2%. Cognizant Technology Solutions pays an annual dividend of $1.32 per share and has a dividend yield of 2.9%. Booz Allen Hamilton pays out 35.1% of its earnings in the form of a dividend. Cognizant Technology Solutions pays out 28.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Booz Allen Hamilton has increased its dividend for 14 consecutive years and Cognizant Technology Solutions has increased its dividend for 6 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Cognizant Technology Solutions beats Booz Allen Hamilton on 12 of the 19 factors compared between the two stocks.

Get Booz Allen Hamilton News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAH vs. The Competition

MetricBooz Allen HamiltonConsulting IndustryBusiness SectorNYSE Exchange
Market Cap$8.84B$4.03B$6.31B$23.00B
Dividend Yield3.13%2.58%3.12%4.07%
P/E Ratio10.9013.8031.7928.39
Price / Sales0.781.94432.5139.21
Price / Cash9.7517.7323.4425.11
Price / Book9.2613.486.744.76
Net Income$935M$251.10M$199.93M$1.06B
7 Day Performance-4.47%-6.36%0.15%-0.74%
1 Month Performance-9.94%-5.51%2.02%1.74%
1 Year Performance-40.65%-28.14%36.62%25.05%

Booz Allen Hamilton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAH
Booz Allen Hamilton
4.3851 of 5 stars
$73.34
+2.4%
$93.33
+27.3%
-42.2%$8.84B$11.41B10.9035,800
CCRN
Cross Country Healthcare
2.2174 of 5 stars
$10.31
+0.8%
$12.53
+21.6%
-5.9%$329.40M$1.05BN/A6,784
SAIC
Science Applications International
4.2753 of 5 stars
$96.86
+1.0%
$110.78
+14.4%
N/A$4.16B$7.26B12.6023,000
CACI
CACI International
4.3654 of 5 stars
$513.66
+0.1%
$641.50
+24.9%
+9.2%$11.34B$8.63B21.1925,000
LDOS
Leidos
4.8654 of 5 stars
$149.48
+0.2%
$202.82
+35.7%
-20.1%$18.82B$17.17B13.4347,000

Related Companies and Tools


This page (NYSE:BAH) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners